Eric L. Bell
Constellation Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Mitochondrial Function and Pathology, Sirtuins and Resveratrol in Medicine, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism
Most-Cited Works
- → Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia(2011)1,755 cited
- → Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging(2013)1,438 cited
- → Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation(2005)752 cited
- → The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production(2007)562 cited
- → Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis(2007)428 cited
- → Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells(2013)361 cited
- → Intrinsic Mechanism of Estradiol-Induced Apoptosis in Breast Cancer Cells Resistant to Estrogen Deprivation(2005)258 cited
- → SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β‐catenin(2013)257 cited
- → SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive(2011)253 cited
- → Mitochondrial Reactive Oxygen Species Trigger Hypoxia-Inducible Factor-Dependent Extension of the Replicative Life Span during Hypoxia(2007)231 cited